OR WAIT null SECS
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Perrigo appoints Keith Webber as head of regulatory review.
Perrigo has appointed Keith Webber as head of regulatory review, effective Oct. 21, 2013 with responsibility for advancing the approval of all of Perrigo's consumer healthcare and prescription pharmaceutical regulatory applications pending with FDA, providing guidance on scientific and regulatory strategy for pipeline products, and advancing the quality of new regulatory applications.
Webber previously was Acting Director of the Office of the FDA's Pharmaceutical Science in the Center for Drug Evaluation and Research.
Source: Perrigo